HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 323 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,662,827 | +16.1% | 46,100 | +22.9% | 0.18% | +1.1% |
| Q1 2023 | $1,432,125 | +231.2% | 37,500 | +393.4% | 0.18% | +181.0% |
| Q4 2022 | $432,440 | -32.1% | 7,600 | -52.8% | 0.06% | -51.2% |
| Q3 2022 | $637,000 | -27.3% | 16,100 | -19.1% | 0.13% | -20.9% |
| Q2 2022 | $876,000 | +147.5% | 19,900 | +155.1% | 0.16% | +77.2% |
| Q2 2021 | $354,000 | +0.3% | 7,800 | -7.9% | 0.09% | +13.6% |
| Q1 2021 | $353,000 | -23.6% | 8,465 | -62.9% | 0.08% | -13.8% |
| Q4 2017 | $462,000 | +376.3% | 22,800 | +103.6% | 0.09% | +62.1% |
| Q2 2016 | $97,000 | – | 11,200 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |